LEADER 00000cam a2200973Mi 4500 001 932818204 003 OCoLC 005 20240129213017.0 006 m o d 007 cr |n||||||||| 008 151218s2016 flua ob 001 0 eng d 019 928883541|a928989804|a961311999|a987456344|a1004622604 |a1010743416|a1048766726 020 9781466505483|q(electronic bk.) 020 1466505486|q(electronic bk.) 024 7 10.1201/b19001|2doi 029 1 AU@|b000057045141 029 1 AU@|b000062437846 029 1 CHBIS|b010877043 029 1 CHSLU|b001223319 029 1 CHVBK|b354931245 029 1 CHVBK|b480375070 029 1 DEBBG|bBV043892575 029 1 AU@|b000057002612 029 1 AU@|b000070351887 029 1 AU@|b000072162188 029 1 AU@|b000069006864 035 (OCoLC)932818204|z(OCoLC)928883541|z(OCoLC)928989804 |z(OCoLC)961311999|z(OCoLC)987456344|z(OCoLC)1004622604 |z(OCoLC)1010743416|z(OCoLC)1048766726 037 852520|bMIL 040 YDXCP|beng|erda|epn|cYDXCP|dOCLCO|dOCLCQ|dOCLCA|dIDEBK |dN$T|dCUS|dCRCPR|dEBLCP|dYDX|dMERUC|dIDB|dOCLCQ|dUAB |dOCLCQ|dOCLCF|dOCLCO|dSTF|dUUM|dNRC|dU3W|dAU@|dOCLCO |dOCLCQ|dWYU|dOCLCA|dLVT|dOCLCA|dOCLCQ|dOCLCO|dOCLCA |dOCLCO|dOCLCQ|dOCLCO 049 INap 082 04 338.4/73621 082 04 338.4/73621|223 099 eBook O'Reilly for Public Libraries 100 1 Khan, Iftekhar,|eauthor. 245 10 Design & analysis of clinical trials for economic evaluation & reimbursement :|ban applied approach using SAS & STATA /|cIftekhar Khan.|h[O'Reilly electronic resource] 246 3 Design and analysis of clinical trials for economic evaluation and reimbursement 264 1 Boca Raton, FL :|bCRC Press, Taylor & Francis Group, |c[2016] 300 1 online resource (xxvi, 313 pages .) 336 text|btxt|2rdacontent 337 computer|bc|2rdamedia 338 online resource|bcr|2rdacarrier 490 1 Chapman & Hall/CRC biostatistics series 500 "Chapman & Hall book." 504 Includes bibliographical references and index. 505 0 1. Introduction to economic evaluation -- 2. Health economic evaluation concepts -- 3. Designing cost- effectiveness into a clinical trial -- 4. Analysing cost data collected in a clinical trial -- 5. Quality of life in economic evaluation -- 6. Modelling in economic evaluation -- 7. Sensitivity analyses -- 8. Sample size and value of information for cost-effectiveness trials -- 9. Mixed treatment comparisons, evidence synthesis -- 10. Cost-effectiveness analyses of cancer trials -- 11. The reimbursement environment. 520 Economic evaluation has become an essential component of clinical trial design to show that new treatments and technologies offer value to payers in various healthcare systems. Although many books exist that address the theoretical or practical aspects of cost-effectiveness analysis, this book differentiates itself from the competition by detailing how to apply health economic evaluation techniques in a clinical trial context, from both academic and pharmaceutical/commercial perspectives. It also includes a special chapter for clinical trials in Cancer. Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement is not just about performing cost-effectiveness analyses. It also emphasizes the strategic importance of economic evaluation and offers guidance and advice on the complex factors at play before, during, and after an economic evaluation. Filled with detailed examples, the book bridges the gap between applications of economic evaluation in industry (mainly pharmaceutical) and what students may learn in university courses. It provides readers with access to SAS and STATA code. In addition, Windows-based software for sample size and value of information analysis is available free of chargeґ �making it a valuable resource for students considering a career in this field or for those who simply wish to know more about applying economic evaluation techniques. The book includes coverage of trial design, case report form design, quality of life measures, sample sizes, submissions to regulatory authorities for reimbursement, Markov models, cohort models, and decision trees. Examples and case studies are provided at the end of each chapter. Presenting first-hand insights into how economic evaluations are performed from a drug development perspective, the book supplies readers with the foundation required to succeed in an environment where clinical trials and cost-effectiveness of new treatments are central. It also includes thought-provoking exercises for use in classroom and seminar discussions.--|cProvided by publisher. 588 0 Print version record. 590 O'Reilly|bO'Reilly Online Learning: Academic/Public Library Edition 650 0 Medical economics. 650 0 Clinical trials|xEconomic aspects. 650 0 Cost effectiveness. 650 0 Statistics. 650 2 Economics, Medical 650 6 Économie de la santé. 650 6 Études cliniques|xAspect économique. 650 6 Coût-efficacité. 650 6 Statistiques. 650 6 Statistique. 650 7 cost benefit analysis.|2aat 650 7 statistics.|2aat 650 7 Cost effectiveness|2fast 650 7 Medical economics|2fast 650 7 Kosten-Nutzen-Analyse|2gnd 650 7 Klinisches Experiment|2gnd 650 7 Stata|2gnd 650 7 SAS|gProgramm|2gnd 650 12 Clinical Trials as Topic|xeconomics 650 12 Cost-Benefit Analysis 650 22 Statistics as Topic 650 22 Research Design 776 08 |iPrint version:|aKhan, Iftekhar.|tDesign & analysis of clinical trials for economic evaluation & reimbursement. |dBoca Raton, FL : CRC Press, Taylor & Francis Group, [2016]|z9781466505476|z1466505478|w(DLC) 2015021743 |w(OCoLC)756596310 830 0 Chapman & Hall/CRC biostatistics series. 856 40 |uhttps://ezproxy.naperville-lib.org/login?url=https:// learning.oreilly.com/library/view/~/9781466505483/?ar |zAvailable on O'Reilly for Public Libraries 938 YBP Library Services|bYANK|n15917515 938 CRC Press|bCRCP|nCAH0KE16068PDF 938 EBL - Ebook Library|bEBLB|nEBL4089965 938 EBSCOhost|bEBSC|n1093880 938 ProQuest MyiLibrary Digital eBook Collection|bIDEB |ncis31821612 938 YBP Library Services|bYANK|n11787029 994 92|bJFN